Strength
200 mg/1
Manufacturer
McKessonNDC
68599805104
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA079174FDA Approved
12/10/2010
On Market Since
9/1/2021
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 200 MG TABLET has been published 202 times since Oct 12, 2022, and over the history we have for it it has declined 8.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0329 per EA |
|---|---|
| All-time high | $0.0370 (Nov 12, 2025) |
| All-time low | $0.0300 (Apr 17, 2024) |
| 52-week high | $0.0370 |
| 52-week low | $0.0320 |
| Median price | $0.0335 |
| Average price | $0.0337 |
| Largest weekly change | -13.7% (Apr 17, 2024) |
| Weeks tracked | 202 |
| Tracking since | Oct 12, 2022 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 200 MG TABLET, manufactured by McKesson, is $0.0329 per EA (NDC 68599805104), effective Aug 19, 2026.
How has the price of IBUPROFEN 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 200 MG TABLET has declined 8.0%. It has been tracked across 202 weekly CMS publications since Oct 12, 2022.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 200 MG TABLET?
Since Oct 12, 2022, the NADAC for IBUPROFEN 200 MG TABLET has ranged from a low of $0.0300 (Apr 17, 2024) to a high of $0.0370 (Nov 12, 2025), with a median of $0.0335 per EA.
Are there cheaper alternatives to IBUPROFEN 200 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 200 MG TABLET, is $0.0269 per EA — about 18% below IBUPROFEN 200 MG TABLET.
Who manufactures IBUPROFEN 200 MG TABLET?
IBUPROFEN 200 MG TABLET (NDC 68599805104) is labeled by McKesson, and CMS classifies it as a generic product.